CHATHAM, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical ...

This is just the beginning." Learn more about how Medable AI is improving clinical trials at the Decentralized Trials and Research Alliance's (DTRA's) Annual Meeting, Friday Nov 15 when executives ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

The conference is being held at the Mandarin Oriental ... a contract with the U.S. DoD’s Defense Threat Reduction Agency (DTRA) for up to $34 million over five years to develop TNX-4200 ...

Aleksandre Darakhvelidze, the Georgian Deputy Interior Minister, and Junji Wakui, the Head of the Japan International ...

The ThinkEquity Conference gathers institutional investors ... of Allergy and Infectious Diseases (NIAID), the Defense Threat Reduction Agency (DTRA) and the Biomedical Advanced Research and ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

The conference, organized in partnership with B2i Digital ... Institute of Allergy and Infectious Diseases (NIAID), the Defense Threat Reduction Agency (DTRA) and the Biomedical Advanced Research and ...

The conference is being held from October 16-19 2024 ... who is working in partnership with the Defense Threat Reduction Agency. These funds along with other potential funding sources, are anticipated ...

The conference is being held at the Mandarin Oriental ... under Tonix’s contract with the Defense Threat Reduction Agency (DTRA), for up to $34 million over five yearsCHATHAM, N.J., Oct ...

New data show tolerability and no evidence of spreading to blood or tissues even at high doses of Tonix's attenuated live-virus, minimally replicatin ...